Cargando…
Patterns of granulocyte colony–stimulating factor prophylaxis in patients with cancer receiving myelosuppressive chemotherapy
PURPOSE: To evaluate patterns of primary prophylactic (PP) granulocyte colony–stimulating factor (G-CSF) use following chemotherapy by cancer type and febrile neutropenia (FN) risk. METHODS: Using a commercial administrative database, we identified adult patients diagnosed with breast, colorectal, l...
Autores principales: | Gawade, Prasad L., Li, Shuling, Henry, David, Smith, Nancy, Belani, Rajesh, Kelsh, Michael A., Bradbury, Brian D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378111/ https://www.ncbi.nlm.nih.gov/pubmed/31919669 http://dx.doi.org/10.1007/s00520-020-05295-2 |
Ejemplares similares
-
A Survey of Oncologists’ Perceptions and Opinions Regarding the Use of Granulocyte Colony-Stimulating Factors
por: Hawkins, Alicia, et al.
Publicado: (2019) -
Interleukin‐6 and Granulocyte Colony‐stimulating Factor Synergistically Increase Peripheral Blood Progenitor Cells in Myelosuppressive Mice
por: Suzuki, Hideki, et al.
Publicado: (1996) -
Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?
por: Aapro, Matti, et al.
Publicado: (2010) -
Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice
por: Averin, Ahuva, et al.
Publicado: (2020) -
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
por: Cooper, Katy L, et al.
Publicado: (2011)